Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation

导出原文传递

翻译打印收藏纠错

作者： Suzuki, Takanori ^[1] ; Inoue, Takako ^[2] ; Matsuura, Kentaro ^[3] ; Kusumoto, Shigeru ^[4] ; Hagiwara, Shinya ^[5] ; Ogawa, Shintaro ^[6] ; Yagi, Shintaro ; Kaneko, Atsushi ; Fujiwara, Kei ; Watanabe, Takehisa ; Aoyagi, Katsumi ; Urata, Yukitomo ; Tamori, Akihiro ; Kataoka, Hiromi ; Tanaka, Yasuhito

作者单位： Grad Sch Med Sci,Nagoya City Univ ^[1] Adv Life Sci Inst Inc ^[2] Fujirebio Inc ^[3] Fac Life Sci,Kumamoto Univ ^[4] United Municipal Tsugaru,Tsugaru Gen Hosp ^[5] Grad Sch Med,Osaka City Univ ^[6]

关键词 Hepatitis B virus (HBV)High-sensitivity hepatitis B core-related antigen assay (HBcrAg)Ultra-high-sensitivity hepatitis B surface antigen assay (iTACT-HBsAg)HBV reactivation VIRUS CORE SURFACE-ANTIGEN ENZYME-IMMUNOASSAY LAMIVUDINE MARKER THERAPY RISK DNA

发布时间 2023-01-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交